COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Effect of Liraglutide on Cardiovascular Endpoints in Diabetes Mellitus Type 2 Patients of South Asian Descent (MAGNA VICTORIA)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02660047
Recruitment Status : Completed
First Posted : January 21, 2016
Last Update Posted : March 21, 2018
Novo Nordisk A/S
Information provided by (Responsible Party):
MalouPaiman, Leiden University Medical Center

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : March 9, 2018
Actual Study Completion Date : March 9, 2018